Dr. Jackson shares results from the phase III Myeloma XI study, which compared patients treated with lenalidomide maintenance therapy or no maintenance therapy in a large population of myeloma patients.
Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients
